||All England Reporter
|| All ER (D) 301 (Apr)
||Court of Justice of the European Communities (Second Chamber)
Judges Timmermans (President of the Chamber), Gulmann (Rapporteur), Puissochet, Schintgen and Cunha Rodrigues
||21 April 2005
Medicinal products - Products for human use - Marketing authorisations - European Community - Supplementary protection certificate for medicinal products - First marketing authorisation - Interpretation of regulation - Council Regulation (EC) 1768/92, art 13.
In so far as an authorisation to place a medicinal product on the market issued by the Swiss authorities and automatically recognised by Liechtenstein under that state's legislation was the first authorisation to place that product on the market in one of the states of the European Economic Area, it constituted the first authorisation to place the product on the market within the meaning of art13 of Council Regulation (EEC) 1768-92 (concerning the creation of a supplementary protection certificate for medicinal products), as it was to be read for the purposes of the application of the Agreement on the European Economic Area.
- The All England Law Reports comprises judgments with headnotes and catchwords indicating the area of law and key issues of the case prepared by legally qualified editorsFind AllER Reports
- Cases related to this particular case that are related to, or discuss this caseView related cases
- Commentary discussing this particular case from LexisLibrary's comprehensive range of titles including Butterworths, Halsbury's and TolleyView related commentary